Skip to main content
Log in

Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim–sulfamethoxazole

  • Case report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Drug-induced pauci-immune crescentic glomerulonephritis has been described with several agents, including propylthiouracil, minocycline, d-penicillamine, and hydralazine. We present the case of a 60-year-old man who presented with rapidly progressive glomerulonephritis in the setting of recent use of trimethoprim–sulfamethoxazole complicated by the development of the Stevens–Johnson syndrome, and was found to have biopsy-proven pauci-immune crescentic glomerulonephritis and undetectable anti-neutrophilic cytoplasmic antibodies. We review the existing literature on the potential association between sulfonamides and hypersensitivity polyangiitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Harada T, Uzu T, Namba T, et al. ANCA-negative pauci-immune crescentic glomerulonephritis complicated with recurrent massive gastrointestinal hemorrhage. Clin Exp Nephrol. 2005;9:174–8.

    Article  PubMed  Google Scholar 

  2. Chow KM, Wang AY, Mac-Moune Lai F, et al. Rapid recurrence of ANCA-negative pauci-immune vasculitis after cadaveric renal transplantation. Am J Kidney Dis. 2001;38:E3.

    Article  CAS  PubMed  Google Scholar 

  3. Fukuda Y, Watanabe H, Ohtomo Y, et al. Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy. Nephron. 1996;72:328–9.

    Article  CAS  PubMed  Google Scholar 

  4. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenic mechanisms, and therapy. Am J Kidney Dis. 1998;6:449–64.

    Google Scholar 

  5. Morgan MD, Harper L, Williams J, et al. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol. 2006;17:1224–34.

    Article  CAS  PubMed  Google Scholar 

  6. Chen M, Yu F, Wang SX, Zou WZ, et al. Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.

    Article  PubMed  Google Scholar 

  7. Hung PH, Chiu YL, Lin WC, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;10:804–12.

    Article  Google Scholar 

  8. Eisenberger U, Fakhouri F, Vanhille P, et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant. 2005;20:1392–9.

    Article  PubMed  Google Scholar 

  9. 19th WHO Model List of Essential Medicines April 2015. http://www.who.int/selection_medicines/committees/expert/20/EML_2015_FINAL_amended_AUG2015.pdf?ua=1 (updated August 2015; cited 20 October 2015).

  10. Hogan JJ, Markowitz GS, Radhakrishnan J. Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015;10(7):1300–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Choi HK, Slot MC, Pan G, et al. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis Rheum. 2000;43:2488–92.

    Article  CAS  PubMed  Google Scholar 

  12. Van Rijssel ThG, Meyler L. Necrotizing generalized arteritis due to the use of sulphonamide drugs. Acta Med Scand. 1948;132:251–64.

    Article  Google Scholar 

  13. Wahlin A, Rosman N. Skin manifestations with vasculitis due to co-trimoxazole. Lancet. 1976;2:1415.

    Article  CAS  PubMed  Google Scholar 

  14. Symmers WS. The occurrence of angiitis and other generalised diseases of connective tissue as a consequence of the administration of drugs. Proc R Soc Med. 1962;55:20–8.

    PubMed Central  Google Scholar 

  15. Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43:405–13.

    Article  CAS  PubMed  Google Scholar 

  16. Shih DJ, Korbet SM, Rydel JJ, Schwartz MM. Renal vasculitis associated with ciprofloxacin. Am J Kidney Dis. 1995;26:516–9.

    Article  CAS  PubMed  Google Scholar 

  17. Bell EK, Chugh SS, Cook WJ. A case of infection-associated antiproteinase-3-negative cytoplasmic antineutrophil cytoplasmic antibody pauci-immune focal necrotizing glomerulonephritis. Nephrol Dial Transplant. 2010;25:3119–23.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hedger N, Stevens J, Drey N, et al. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15:1593–9.

    Article  CAS  PubMed  Google Scholar 

  19. Chen S, Tang Z, Xiang H, et al. Etiology and outcome of crescentic glomerulonephritis from a single center in china: a 10-year review. Am J Kidney Dis. 2016;67:376–83. doi:10.1053/j.ajkd.2015.07.034.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bertrand L. Jaber.

Ethics declarations

Conflict of interest

All the authors have declared no competing interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hegde, S.S., Bijol, V. & Jaber, B.L. Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim–sulfamethoxazole. CEN Case Rep 5, 188–191 (2016). https://doi.org/10.1007/s13730-016-0222-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-016-0222-5

Keywords

Navigation